OUTLOOK THERAPEUTICS (OTLK) SWOT Analysis / TOWS Matrix / MBA Resources

Introduction to SWOT Analysis

SWOT Analysis / TOWS Matrix for OUTLOOK THERAPEUTICS (United States)

Based on various researches at Oak Spring University , OUTLOOK THERAPEUTICS is operating in a macro-environment that has been destablized by – there is backlash against globalization, wage bills are increasing, geopolitical disruptions, increasing household debt because of falling income levels, customer relationship management is fast transforming because of increasing concerns over data privacy, there is increasing trade war between United States & China, increasing inequality as vast percentage of new income is going to the top 1%, increasing energy prices, banking and financial system is disrupted by Bitcoin and other crypto currencies, etc

---

---

---

---

Introduction to SWOT Analysis of OUTLOOK THERAPEUTICS

SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University, we believe that OUTLOOK THERAPEUTICS can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the OUTLOOK THERAPEUTICS, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which OUTLOOK THERAPEUTICS operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.

---

SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix

SWOT analysis of OUTLOOK THERAPEUTICS can be done for the following purposes –
1. Strategic planning of OUTLOOK THERAPEUTICS
2. Improving business portfolio management of OUTLOOK THERAPEUTICS
3. Assessing feasibility of the new initiative in United States
4. Making a Biotechnology & Drugs sector specific business decision
5. Set goals for the organization
6. Organizational restructuring of OUTLOOK THERAPEUTICS

---

Strengths of OUTLOOK THERAPEUTICS | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of OUTLOOK THERAPEUTICS are -

High brand equity

– OUTLOOK THERAPEUTICS has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled OUTLOOK THERAPEUTICS to keep acquiring new customers and building profitable relationship with both the new and loyal customers.

Strong track record of project management in the Biotechnology & Drugs industry

– OUTLOOK THERAPEUTICS is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

Low bargaining power of suppliers

– Suppliers of OUTLOOK THERAPEUTICS in the Healthcare sector have low bargaining power. OUTLOOK THERAPEUTICS has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps OUTLOOK THERAPEUTICS to manage not only supply disruptions but also source products at highly competitive prices.

Training and development

– OUTLOOK THERAPEUTICS has one of the best training and development program in Healthcare industry. The effectiveness of the training programs can be measured in – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.

Sustainable margins compare to other players in Biotechnology & Drugs industry

– OUTLOOK THERAPEUTICS has clearly differentiated products in the market place. This has enabled OUTLOOK THERAPEUTICS to fetch slight price premium compare to the competitors in the Biotechnology & Drugs industry. The sustainable margins have also helped OUTLOOK THERAPEUTICS to invest into research and development (R&D) and innovation.

Innovation driven organization

– OUTLOOK THERAPEUTICS is one of the most innovative firm in Biotechnology & Drugs sector.

Operational resilience

– The operational resilience strategy of OUTLOOK THERAPEUTICS comprises – understanding the underlying the factors in the Biotechnology & Drugs industry, building diversified operations across different geographies so that disruption in one part of the world doesn’t impact the overall performance of the firm, and integrating the various business operations and processes through its digital transformation drive.

Organizational Resilience of OUTLOOK THERAPEUTICS

– The covid-19 pandemic has put organizational resilience at the centre of everthing OUTLOOK THERAPEUTICS does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.

High switching costs

– The high switching costs that OUTLOOK THERAPEUTICS has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.

Highly skilled collaborators

– OUTLOOK THERAPEUTICS has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive Biotechnology & Drugs industry. Secondly the value chain collaborators of OUTLOOK THERAPEUTICS have helped the firm to develop new products and bring them quickly to the marketplace.

Learning organization

- OUTLOOK THERAPEUTICS is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at OUTLOOK THERAPEUTICS is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders at OUTLOOK THERAPEUTICS emphasize – knowledge, initiative, and innovation.

Analytics focus

– OUTLOOK THERAPEUTICS is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the Biotechnology & Drugs industry. The technology infrastructure of United States is also helping it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.

---

---

Weaknesses of OUTLOOK THERAPEUTICS | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of OUTLOOK THERAPEUTICS are -

Skills based hiring in Biotechnology & Drugs industry

– The stress on hiring functional specialists at OUTLOOK THERAPEUTICS has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.

Ability to respond to the competition

– As the decision making is very deliberative at OUTLOOK THERAPEUTICS, in the dynamic environment of Biotechnology & Drugs industry it has struggled to respond to the nimble upstart competition. OUTLOOK THERAPEUTICS has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.

High dependence on OUTLOOK THERAPEUTICS ‘s star products

– The top 2 products and services of OUTLOOK THERAPEUTICS still accounts for major business revenue. This dependence on star products in Biotechnology & Drugs industry has resulted into insufficient focus on developing new products, even though OUTLOOK THERAPEUTICS has relatively successful track record of launching new products.

High dependence on existing supply chain

– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of OUTLOOK THERAPEUTICS supply chain. Even after few cautionary changes, OUTLOOK THERAPEUTICS is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left OUTLOOK THERAPEUTICS vulnerable to further global disruptions in South East Asia.

Slow decision making process

– As mentioned earlier in the report, OUTLOOK THERAPEUTICS has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the Biotechnology & Drugs industry over the last five years. OUTLOOK THERAPEUTICS even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.

Increasing silos among functional specialists

– The organizational structure of OUTLOOK THERAPEUTICS is dominated by functional specialists. It is not different from other players in the Biotechnology & Drugs industry, but OUTLOOK THERAPEUTICS needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help OUTLOOK THERAPEUTICS to focus more on services in the Biotechnology & Drugs industry rather than just following the product oriented approach.

Slow to harness new channels of communication

– Even though competitors are using new communication channels such as Instagram, Tiktok, and Snap, OUTLOOK THERAPEUTICS is slow explore the new channels of communication. These new channels of communication can help OUTLOOK THERAPEUTICS to provide better information regarding Biotechnology & Drugs products and services. It can also build an online community to further reach out to potential customers.

Products dominated business model

– Even though OUTLOOK THERAPEUTICS has some of the most successful models in the Biotechnology & Drugs industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. OUTLOOK THERAPEUTICS should strive to include more intangible value offerings along with its core products and services.

Slow to strategic competitive environment developments

– As OUTLOOK THERAPEUTICS is one of the leading players in the Biotechnology & Drugs industry, it takes time to assess the upcoming competitions. This has led to missing out on atleast 2-3 big opportunities in the Biotechnology & Drugs industry in last five years.

Employees’ less understanding of OUTLOOK THERAPEUTICS strategy

– From the outside it seems that the employees of OUTLOOK THERAPEUTICS don’t have comprehensive understanding of the firm’s strategy. This is reflected in number of promotional campaigns over the last few years that had mixed messaging and competing priorities. Some of the strategic activities and services promoted in the promotional campaigns were not consistent with the organization’s strategy.

High operating costs

– Compare to the competitors, OUTLOOK THERAPEUTICS has high operating costs in the Biotechnology & Drugs industry. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract OUTLOOK THERAPEUTICS lucrative customers.

---

OUTLOOK THERAPEUTICS Opportunities | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The opportunities of OUTLOOK THERAPEUTICS are -

Harnessing reconfiguration of the global supply chains

– As the trade war between US and China heats up in the coming years, OUTLOOK THERAPEUTICS can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help OUTLOOK THERAPEUTICS to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.

Leveraging digital technologies

– OUTLOOK THERAPEUTICS can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.

Use of Bitcoin and other crypto currencies for transactions in Biotechnology & Drugs industry

– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for OUTLOOK THERAPEUTICS in the Biotechnology & Drugs industry. Now OUTLOOK THERAPEUTICS can target international markets with far fewer capital restrictions requirements than the existing system.

Lowering marketing communication costs

– 5G expansion will open new opportunities for OUTLOOK THERAPEUTICS in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Biotechnology & Drugs industry, and it will provide faster access to the consumers.

Developing new processes and practices

– OUTLOOK THERAPEUTICS can develop new processes and procedures in Biotechnology & Drugs industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.

Better consumer reach

– The expansion of the 5G network will help OUTLOOK THERAPEUTICS to increase its market reach. OUTLOOK THERAPEUTICS will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.

Loyalty marketing

– OUTLOOK THERAPEUTICS has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.

Manufacturing automation

– OUTLOOK THERAPEUTICS can use the latest technology developments to improve its manufacturing and designing process in Biotechnology & Drugs sector. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.

Reforming the budgeting process

- By establishing new metrics that will be used to evaluate both existing and potential projects OUTLOOK THERAPEUTICS can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.

Buying journey improvements

– OUTLOOK THERAPEUTICS can improve the customer journey of consumers in the Biotechnology & Drugs industry by using analytics and artificial intelligence. It can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.

Creating value in data economy

– The success of analytics program of OUTLOOK THERAPEUTICS has opened avenues for new revenue streams for the organization in Biotechnology & Drugs industry. This can help OUTLOOK THERAPEUTICS to build a more holistic ecosystem for OUTLOOK THERAPEUTICS products in the Biotechnology & Drugs industry by providing – data insight services, data privacy related products, data based consulting services, etc.

Identify volunteer opportunities

– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. OUTLOOK THERAPEUTICS can explore opportunities that can attract volunteers and are consistent with its mission and vision.

Building a culture of innovation

– managers at OUTLOOK THERAPEUTICS can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Biotechnology & Drugs industry.

---

Threats OUTLOOK THERAPEUTICS External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The threats of OUTLOOK THERAPEUTICS are -

High level of anxiety and lack of motivation

– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. OUTLOOK THERAPEUTICS needs to understand the core reasons impacting the Biotechnology & Drugs industry. This will help it in building a better workplace.

Technology disruption because of hacks, piracy etc

– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.

Regulatory challenges

– OUTLOOK THERAPEUTICS needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Biotechnology & Drugs industry regulations.

Technology acceleration in Forth Industrial Revolution

– OUTLOOK THERAPEUTICS has witnessed rapid integration of technology during Covid-19 in the Biotechnology & Drugs industry. As one of the leading players in the industry, OUTLOOK THERAPEUTICS needs to keep up with the evolution of technology in the Biotechnology & Drugs sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.

Aging population

– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.

Increasing wage structure of OUTLOOK THERAPEUTICS

– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of OUTLOOK THERAPEUTICS.

High dependence on third party suppliers

– OUTLOOK THERAPEUTICS high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.

Easy access to finance

– Easy access to finance in Biotechnology & Drugs industry will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. OUTLOOK THERAPEUTICS can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry to Biotechnology & Drugs industry are lowering. It can presents OUTLOOK THERAPEUTICS with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the Biotechnology & Drugs sector.

New competition

– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for OUTLOOK THERAPEUTICS in the Biotechnology & Drugs sector and impact the bottomline of the organization.

Increasing international competition and downward pressure on margins

– Apart from technology driven competitive advantage dilution, OUTLOOK THERAPEUTICS can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate OUTLOOK THERAPEUTICS prominent markets.

Shortening product life cycle

– it is one of the major threat that OUTLOOK THERAPEUTICS is facing in Biotechnology & Drugs sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.

Instability in the European markets

– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. OUTLOOK THERAPEUTICS will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.

---

Weighted SWOT Analysis of OUTLOOK THERAPEUTICS Template, Example

Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers at OUTLOOK THERAPEUTICS needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of OUTLOOK THERAPEUTICS is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of OUTLOOK THERAPEUTICS is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of OUTLOOK THERAPEUTICS to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that OUTLOOK THERAPEUTICS needs to make to build a sustainable competitive advantage.

--- ---